Bain Capital and Cinven are speaking with investors – mainly with hedge funds – about the terms of a potential new offer for German generic drug maker Stada (STAGn.DE) after its first tender offer fell through, people close to the matter said.
Before launching a new offer, however, Bain and Cinven want irrevocable commitments from investors that they will tender their shares, the people said.
Cinven declined to comment, while Bain was not immediately available for comment.
READ FULL ARTICLE HERE
